Primary Recipient

PLX PHARMA INC

Amount

$798,642.00

Award Date

4/30/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

PLx Pharma is a pharmaceutical company developing GI safer formulations of proven nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen, aspirin, and naproxen. PLx has created novel NSAID formulations, using a natural gastroprotective agent,